Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer

Early-onset colorectal cancer (EOCRC), defined as a diagnosis under age 50, is an emerging public health burden. As many of these individuals fall outside of screening guidelines, the development of a minimally invasive, accurate screening modality for this population is warranted. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Loomans-Kropp, Holli A., Song, Yurong, Gala, Manish, Parikh, Aparna R., Van Seventer, Emily E., Alvarez, Rocio, Hitchins, Megan P., Shoemaker, Robert H., Umar, Asad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387652/
https://www.ncbi.nlm.nih.gov/pubmed/35992328
http://dx.doi.org/10.1158/2767-9764.CRC-21-0142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387652/
https://www.ncbi.nlm.nih.gov/pubmed/35992328
http://dx.doi.org/10.1158/2767-9764.CRC-21-0142

Ejemplares similares